VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 701 filers reported holding VANECK VECTORS ETF TR in Q2 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $208,092 | -14.7% | 6,433 | +1.3% | 0.15% | -5.6% |
| Q1 2022 | $244,000 | +20.2% | 6,353 | 0.0% | 0.16% | +22.0% |
| Q4 2021 | $203,000 | +8.6% | 6,353 | +0.0% | 0.13% | +12.8% |
| Q3 2021 | $187,000 | -65.2% | 6,352 | -59.9% | 0.12% | -63.8% |
| Q2 2021 | $537,000 | +18.5% | 15,822 | +13.3% | 0.32% | +8.0% |
| Q1 2021 | $453,000 | +117.8% | 13,960 | +141.2% | 0.30% | +99.3% |
| Q4 2020 | $208,000 | -8.0% | 5,787 | +9.1% | 0.15% | -17.6% |
| Q3 2020 | $226,000 | -13.7% | 5,304 | -14.3% | 0.18% | -11.2% |
| Q2 2020 | $262,000 | +48.0% | 6,187 | -19.8% | 0.20% | +17.1% |
| Q1 2020 | $177,000 | -46.4% | 7,719 | -31.4% | 0.18% | -34.7% |
| Q4 2019 | $330,000 | +19.6% | 11,256 | +9.0% | 0.27% | -9.5% |
| Q3 2019 | $276,000 | – | 10,323 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hollow Brook Wealth Management LLC | 711,589 | $25,631,000 | 15.27% |
| Sloane Robinson LLP | 450,000 | $16,209,000 | 15.04% |
| New Harbor Financial Group, LLC | 1,103,389 | $39,744,000 | 14.30% |
| Brown University | 541,096 | $19,490,000 | 14.10% |
| Grand Central Investment Group | 426,777 | $15,373,000 | 13.75% |
| New Harbor Financial Group, LLC | 1,055,400 | $38,015,000 | 13.68% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $26,601,000 | 11.26% |
| Brevan Howard Capital Management LP | 1,420,000 | $51,148,000 | 10.26% |
| Nokomis Capital, L.L.C. | 603,528 | $21,739,000 | 9.52% |
| tru Independence LLC | 139,120 | $5,011,102,000 | 9.10% |